During the recent session, Astera Labs Inc (NASDAQ:ALAB)’s traded shares were 1.1 million. At the last check today, the stock’s price was $106.35, reflecting an intraday gain of 2.14% or $2.23. The 52-week high for the ALAB share is $108.37, that puts it down -1.9 from that peak though still a striking 65.94% gain since the share price plummeted to a 52-week low of $36.22. The company’s market capitalization is $16.87B, and the average intraday trading volume over the past 10 days was 5.54 million shares, and the average trade volume was 4.52 million shares over the past three months.
Astera Labs Inc (ALAB) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.23. ALAB has a Sell rating from 0 analyst(s) out of 7 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 6 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.26.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Astera Labs Inc (NASDAQ:ALAB) trade information
Astera Labs Inc (ALAB) registered a 2.14% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 2.14% in intraday trading to $106.35, hitting a weekly high. The stock’s 5-day price performance is 23.02%, and it has moved by 51.28% in 30 days. The short interest in Astera Labs Inc (NASDAQ:ALAB) is 10.64 million shares and it means that shorts have 2.9 day(s) to cover.
The consensus price target of analysts on Wall Street is $92.5, which implies a decrease of -14.97% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $65 and $110 respectively. As a result, ALAB is trading at a discount of -3.43% off the target high and 38.88% off the low.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 127.91M as predicted by 10 analyst(s). Meanwhile, a consensus of 9 analyst(s) estimates revenue growth to 133.96M by the end of current fiscal year.
While earnings are projected to return 701.41% in 2024.
ALAB Dividends
Astera Labs Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Astera Labs Inc (NASDAQ:ALAB)’s Major holders
Astera Labs Inc insiders own 16.76% of total outstanding shares while institutional holders control 58.16%, with the float percentage being 69.88%.
Also, the Mutual Funds coming in first place with the largest holdings of Astera Labs Inc (ALAB) shares are Fidelity Select Portfolios – Semiconductors Portfolio and Fidelity Blue Chip Growth Fund. Data provided on Sep 30, 2024 indicates that Fidelity Select Portfolios – Semiconductors Portfolio owns about 7.17 shares. This amounts to just over 4.52 percent of the company’s overall shares, with a $757.24 million market value. The same data shows that the other fund manager holds slightly less at 3.22, or about 2.03% of the stock, which is worth about $339.68 million.
